Metastatic disease of the breast and local recurrence of breast cancer |
| |
Authors: | Eleri L DaviesHelen M Sweetland |
| |
Institution: | Eleri L Davies MB BCh FRCS is a Specialist Registrar at the Royal Glamorgan Hospital, Llantrisant, UK. Conflicts of interest: none; Helen M Sweetland MD FRCS (Ed) is a Reader in Surgery and Honorary Consultant Surgeon at Cardiff and Vale University LHB, Cardiff, UK. Conflicts of interest: none |
| |
Abstract: | Breast cancer is a major health problem worldwide with over one million new cases diagnosed each year. The aim of treatment is to achieve good loco-regional control, provide appropriate adjuvant therapy and treat potential micro-metastasis. Good loco-regional control is essential to minimize local recurrence rates with histological clear margin being the most important factor. Several prognostic factors can be used to guide suitable adjuvant therapy. The most important is hormone sensitivity and the use of hormone manipulation has improved both recurrence rates and overall survival. Early detection with breast screening and better treatment options have improved outcome, but still 35–40% of patients will eventually present with metastatic disease. Metastatic disease is incurable, but several therapies have been shown to maintain a good quality of life whilst prolonging survival. A multidisciplinary team approach is essential to obtain the diagnosis and plan the appropriate treatment. The diagnosis of metastatic disease brings distress to patients and their relatives and support should be available from palliative care teams. |
| |
Keywords: | Breast cancer local recurrence metastatic disease |
本文献已被 ScienceDirect 等数据库收录! |